Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6111]

Pembrolizumab delivers longer overall survival in advanced urothelial carcinoma

Pembrolizumab delivers longer overall survival in advanced urothelial carcinoma

RNA interference shows potential, with candidates for prostate and breast cancers

RNA interference shows potential, with candidates for prostate and breast cancers

Drug combination delivered by nanoparticles may help melanoma treatment

Drug combination delivered by nanoparticles may help melanoma treatment

Tamoxifen dampens immune response, protecting retina from damage

Tamoxifen dampens immune response, protecting retina from damage

$FDA grants accelerated approval to pembrolizumab for refractory Hodgkins lymphoma$

FDA grants accelerated approval to pembrolizumab for refractory Hodgkins lymphoma

Reducing radiation could safely cut breast cancer treatment costs

Reducing radiation could safely cut breast cancer treatment costs

Novel antibody-drug conjugate shows promise for triple-negative breast cancer

Novel antibody-drug conjugate shows promise for triple-negative breast cancer

Moesin found to control regulatory T cells and TGF, indicating immunotherapeutic poteni

Moesin found to control regulatory T cells and TGF, indicating immunotherapeutic poteni

Genetic similarities open up treatment options for non-BRCA breast tumours

Genetic similarities open up treatment options for non-BRCA breast tumours

Mechanism triggering spread of prostate cancer to bones found

Mechanism triggering spread of prostate cancer to bones found

More from ecancer